Cargando…

Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition

OBJECTIVES: To examine whether it is more efficacious to commence exercise medicine in men with prostate cancer at the onset of androgen‐deprivation therapy (ADT) rather than later on during treatment to preserve bone and soft‐tissue composition, as ADT results in adverse effects including: reduced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taaffe, Dennis R., Galvão, Daniel A., Spry, Nigel, Joseph, David, Chambers, Suzanne K., Gardiner, Robert A., Hayne, Dickon, Cormie, Prue, Shum, David H.K., Newton, Robert U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Urological Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635752/ https://www.ncbi.nlm.nih.gov/pubmed/30239116 http://dx.doi.org/10.1111/bju.14505

Ejemplares similares

Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?
por: Newton, Robert U, et al.
Publicado: (2012)

Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial)
por: Galvão, Daniel A, et al.
Publicado: (2022)

Nationwide Industry-Led Community Exercise Program for Men With Locally Advanced, Relapsed, or Metastatic Prostate Cancer on Androgen-Deprivation Therapy
por: Schumacher, Oliver, et al.
Publicado: (2022)

Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer
por: Newton, Robert U., et al.
Publicado: (2020)

Psychological distress in men with prostate cancer undertaking androgen deprivation therapy: modifying effects of exercise from a year-long randomized controlled trial
por: Galvão, Daniel A., et al.
Publicado: (2021)

Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies
por: Cormie, Prue, et al.
Publicado: (2014)

Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation
por: Wall, Bradley A., et al.
Publicado: (2015)

Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial
por: Galvão, Daniel A, et al.
Publicado: (2018)

Painless Visible Haematuria in Adults: An Algorithmic Approach Guiding Management
por: Dulku, Gurjeet, et al.
Publicado: (2019)

Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: a randomized controlled trial
por: Galvão, Daniel A, et al.
Publicado: (2011)

Physical Activity and Survival among Long-term Cancer Survivor and Non-Cancer Cohorts
por: Gunnell, Anthony S., et al.
Publicado: (2017)

Implementing exercise in cancer care: study protocol to evaluate a community-based exercise program for people with cancer
por: Cormie, Prue, et al.
Publicado: (2017)

Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer
por: Delgado, Jessica, et al.
Publicado: (2022)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases
por: GALVÃO, DANIEL A., et al.
Publicado: (2018)

(89)Zirconium-labelled girentuximab ((89)Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma
por: Al-Zubaidi, Mohammed, et al.
Publicado: (2022)

A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer
por: Newton, Robert U, et al.
Publicado: (2009)

Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial
por: Newton, Robert U, et al.
Publicado: (2019)

Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer
por: White, I D, et al.
Publicado: (2015)

Association between ischaemic bowel syndromes and androgen deprivation therapy in patients with prostate cancer: a retrospective cohort study
por: Chiang, I-Ni, et al.
Publicado: (2017)

Acute Inflammatory Response to Low-, Moderate-, and High-Load Resistance Exercise in Women With Breast Cancer–Related Lymphedema
por: Cormie, Prue, et al.
Publicado: (2015)

Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer
por: Boyd, Kathleen A, et al.
Publicado: (2015)

Androgen deprivation therapy and the risk of iron-deficiency anaemia among patients with prostate cancer: a population-based cohort study
por: Wu, Fang-Jen, et al.
Publicado: (2020)

Weight Loss for Obese Prostate Cancer Patients on Androgen Deprivation Therapy
por: WILSON, REBEKAH L., et al.
Publicado: (2021)

Group-based exercise in daily clinical practice to improve physical fitness in men with prostate cancer undergoing androgen deprivation therapy: study protocol
por: Østergren, Peter, et al.
Publicado: (2016)

Effectiveness of cognitive behavioural therapy on quality of life in patients with prostate cancer after androgen deprivation therapy: a protocol for systematic review and meta-analysis
por: Yuan, Fan, et al.
Publicado: (2021)

Stereotactic body radiotherapy (SBRT) versus androgen deprivation therapy (ADT) for oligometastatic prostate cancer: protocol for a prospective randomised control clinical trial
por: Zhao, Xianzhi, et al.
Publicado: (2022)

Exercise intervention and sexual function in advanced prostate cancer: a randomised controlled trial
por: Galvão, Daniel A, et al.
Publicado: (2022)

The Potential Role of Exercise in Neuro-Oncology
por: Cormie, Prue, et al.
Publicado: (2015)

Transrectal ultrasound biopsy of the prostate: does it still have a role in prostate cancer diagnosis?
por: Moe, Andrew, et al.
Publicado: (2020)

Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol
por: Siltari, Aino, et al.
Publicado: (2022)

Using Exercise and Nutrition to Alter Fat and Lean Mass in Men with Prostate Cancer Receiving Androgen Deprivation Therapy: A Narrative Review
por: Wilson, Rebekah L., et al.
Publicado: (2021)

Factors Associated With Restarting Androgenic Anabolic Steroids After Cessation in Men With Infertility: A Retrospective Analysis
por: White, Josh, et al.
Publicado: (2023)

Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy
por: Sun, Qi, et al.
Publicado: (2023)

Exercise modulation of tumour perfusion and hypoxia to improve radiotherapy response in prostate cancer
por: Schumacher, Oliver, et al.
Publicado: (2020)

Feasibility and Preliminary Efficacy of a 10-Week Resistance and Aerobic Exercise Intervention During Neoadjuvant Chemoradiation Treatment in Rectal Cancer Patients
por: Singh, Favil, et al.
Publicado: (2018)

Prehabilitative versus rehabilitative exercise in prostate cancer patients undergoing prostatectomy
por: Singh, Favil, et al.
Publicado: (2023)

High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial
por: Nair-Shalliker, Visalini, et al.
Publicado: (2021)

The effects of home-based exercise therapy for breast cancer-related fatigue induced by radical radiotherapy
por: Mavropalias, Georgios, et al.
Publicado: (2022)

Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer
por: Ihrig, Andreas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_17f87ab3d86m7ia31pm007els5